17
Feb
2009
Compound Can Distinguish Between Benign, Localized And Metastatic Prostate Cancer
Researchers have determined that a molecule produced by the body’s metabolism could be used to differentiate between benign prostate tissue vs. localized and metastatic prostate cancer. They also found that this molecule, known as sarcosine, may be associated with prostate cancer invasiveness and aggressiveness.
Related posts:
- Compound Can Distinguish Between Benign, Localized And Metastatic Prostate Cancer (Medical News Today)
- Compound can distinguish between benign tissue and localized and metastatic prostate cancer
- Scientists Hopeful Of Simple Urine Test For Prostate Cancer
- Dendreon Presents Preclinical Data Demonstrating Activity Of TRPM8 Agonist, D-3263, In Benign Prostatic Hyperplasia
- Significance Of Preoperative HbA1c Level In Patients With Diabetes Mellitus And Clinically Localized Prostate Cancer
Tags: research [Read the full article here]
